| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/19/2004 | DE10237423A1 Treating immunological (or related) diseases, e.g. inflammatory bowel disease, rheumatoid arthritis or psoriasis, comprises administration of 3-methylene-2-indolinone derivative or quinazoline compound |
| 02/19/2004 | CA2495516A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | CA2495502A1 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | CA2494865A1 Electrospun amorphous pharmaceutical compositions |
| 02/19/2004 | CA2494827A1 Cannabinoid receptor ligands |
| 02/19/2004 | CA2494636A1 Organic compounds as agents for the treatment of aldosterone mediated conditions |
| 02/18/2004 | EP1389237A2 Novel fibroblast growth factors |
| 02/18/2004 | EP1389206A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 02/18/2004 | EP1389204A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 02/18/2004 | EP1389202A1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 02/18/2004 | EP1389137A2 Compositions for protein delivery via the pulmonary route |
| 02/18/2004 | EP1389110A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 02/18/2004 | EP1389104A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 02/18/2004 | EP1183252B1 pharmaceutically active compounds |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 02/18/2004 | EP1143988B1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases |
| 02/18/2004 | EP1133494B1 8-azabicyclo 3.2.1]oct-2-ene and -octane derivatives |
| 02/18/2004 | EP1032396B1 Sterilization of glucocorticosteroids |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1475269A Rhizoma cimicifugae extract and its preparation method |
| 02/18/2004 | CN1138774C Substituted 6,6-hetero-bicyclic derivatives |
| 02/18/2004 | CN1138771C 6-hydroxy-3-(4-[2-piperidine-1-group) oxyethyl group] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride salt |
| 02/18/2004 | CN1138770C 6-carbonyl-3-(4-[2-pierid-1-yl)elhoyl]phenoxy)-2-(4-methoxylphenyl) benzo[b] thiophene salt crystal |
| 02/18/2004 | CN1138591C Coated particles, method of making and using |
| 02/18/2004 | CN1138547C Hormonal medicaments for correcting oestrogen deficiencies |
| 02/17/2004 | US6693096 Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
| 02/17/2004 | US6693090 19-norsteroids substituted in position 11β, preparation process and intermediates, application as medicines and pharmaceutical compositions containing them |
| 02/17/2004 | US6692744 Betaglycan as an inhibin receptor and uses thereof |
| 02/12/2004 | WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 02/12/2004 | WO2004013104A1 Novel tetrahydroquinoline derivatives |
| 02/12/2004 | WO2004012761A1 Methods of use of compounds with preptin function |
| 02/12/2004 | WO2004012758A1 Use of tgf beta ig-h3 for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 02/12/2004 | WO2004012754A1 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 02/12/2004 | WO2004012686A2 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use |
| 02/12/2004 | WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 02/12/2004 | WO2003079885A3 Inhalable sustained therapeutic formulations |
| 02/12/2004 | WO2003053325A8 Microencapsulation of drugs by solvent exchange |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | US20040030165 14 Beta, 16, 17-methylene steroids as novel androgens |
| 02/12/2004 | US20040029993 E-ptfe foil impregnated with an encapsulated bioative substance |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029926 Thiazolidinone nitrate salt |
| 02/12/2004 | US20040029849 Methods for increasing the therapeutic response to electroconvulsive therapy |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029846 Cushing disease; antidepressant; modulate immunology response |
| 02/12/2004 | US20040029803 Binding to apoptosis cells |
| 02/12/2004 | US20040029801 Antiinflammatory agents; immunosuppressants; inflammatory bowel disease; antiarthritic agents; autoimmune diseases; administering drug and immunosuppressant |
| 02/12/2004 | US20040029794 Immobilizated growth hormone releasing factor |
| 02/12/2004 | US20040029784 Administering glucagon-like peptide; reducing insulin resistance |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029202 By determining a level of an estrogen- related marker; screening patient for hormone replacement therapy (HRT), and of monitoring such patients once they begin HRT; treating peri-, menopausal or postmenopausal women |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040028745 Mixture for sustained release; crosslinked alginate; anticancer agents |
| 02/12/2004 | US20040028733 Therapy for fertility disorders; stabilized follicle stimulating hormone |
| 02/12/2004 | US20040028723 Matrix with permeable reservoir containing ergoline compound; diffusion barrier |
| 02/12/2004 | US20040028707 Enhanced pharmacokinetic profile of intradermally delivered substances |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | US20040028615 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/12/2004 | CA2494308A1 Methods of use of compounds with preptin function |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387825A1 Thyroid hormone receptor antagonists for cardiac & metabolic disorders ii |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387697A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21 |
| 02/11/2004 | CN1474819A Novel imidazole derivatives, production method thereof and use thereof |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474695A Adhesive preparation containing estradiol |
| 02/11/2004 | CN1474690A Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1474685A Polymeric delivery formulations of leuprolide with improved efficacy |
| 02/11/2004 | CN1137898C Analogs of parathyroid hormone |
| 02/11/2004 | CN1137891C Process for preparing growth hormone cinogenic agent |
| 02/11/2004 | CN1137722C Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens |
| 02/11/2004 | CN1137690C Pharmaceutical comined preparation, kit and method for hormonal contraception |
| 02/11/2004 | CN1137689C Drug delivery compositions for stability of steroids |
| 02/10/2004 | US6689938 Administering an antagonist of melanocortin stimulating hormone (msh) biological activity. |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689798 Benzofuran derivatives |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689404 Iodinated protein which includes at least phenylalanine or tryptophan; iodinated lactoglobulin |
| 02/10/2004 | US6689365 Follicle stimulating hormone, luteinizing hormone; varying ratios of lh activity as compared to fsh activity; fsh beta is linked through a linker to lh beta; the alpha subunit is downstream from both; fusion protein |
| 02/10/2004 | CA2114936C Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011012A2 Stem cells for treating pancreatic damage |
| 02/05/2004 | WO2004010974A2 Gelatin capsule exhibiting reduced cross-linking |
| 02/05/2004 | WO2004010973A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 02/05/2004 | WO2004010972A2 Pellicle-resistant gelatin capsule |
| 02/05/2004 | WO2003072735A3 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 02/05/2004 | WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2004 | WO2002098355A3 Methods and reagents for diagnosis and treatment of insulin resistance and related conditions |
| 02/05/2004 | US20040024231 Such as 17-beta-hydroxy-17-alpha-trifluoromethyl-7-alpha-methyl-androst-4-en-3-one; for hormone replacement therapy |
| 02/05/2004 | US20040024218 Novel compounds |